|
NPAT expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.03330000111868E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.24729999995132E-06 |
| Normal-vs-Stage2 |
6.55459997389585E-09 |
| Normal-vs-Stage3 |
6.97149999950852E-07 |
| Normal-vs-Stage4 |
3.94429999772683E-08 |
| Stage1-vs-Stage2 |
9.736300E-03 |
| Stage1-vs-Stage3 |
2.933200E-01 |
| Stage1-vs-Stage4 |
4.849500E-02 |
| Stage2-vs-Stage3 |
1.048210E-01 |
| Stage2-vs-Stage4 |
5.528200E-01 |
| Stage3-vs-Stage4 |
2.949000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.64769999655823E-08 |
| Normal-vs-AfricanAmerican |
5.239500E-03 |
| Normal-vs-Asian |
9.59879999999913E-05 |
| Caucasian-vs-AfricanAmerican |
4.663800E-01 |
| Caucasian-vs-Asian |
7.550000E-01 |
| AfricanAmerican-vs-Asian |
6.441800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.63470004199695E-09 |
| Normal-vs-Female |
1.83870000003417E-07 |
| Male-vs-Female |
6.134100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.360240E-04 |
| Normal-vs-Age(41-60Yrs) |
4.8744996927752E-10 |
| Normal-vs-Age(61-80Yrs) |
1.00359999977151E-07 |
| Normal-vs-Age(81-100Yrs) |
3.960300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.964200E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.693700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.759600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.493400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.193000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.041000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.183000E-01 |
| Classical-VS-Follicular |
1.68192999999706E-05 |
| Classical-VS-Other |
1.933990E-01 |
| Classical-VS-Normal |
3.85439999994741E-06 |
| Tall-VS-Follicular |
1.370200E-02 |
| Tall-VS-Other |
2.418400E-01 |
| Tall-VS-Normal |
2.500100E-03 |
| Follicular-VS-Other |
8.742400E-01 |
| Follicular-VS-Normal |
3.32950333969961E-11 |
| Other-VS-Normal |
3.016100E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.0536997636973E-10 |
| Normal-vs-N1 |
3.01190000051577E-07 |
| N0-vs-N1 |
7.239000E-01 |
|
|
